The human microbiome in chronic kidney disease: a double-edged sword
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …
[HTML][HTML] Ten lessons from the Spanish model of organ donation and transplantation
S Streit, C Johnston-Webber, J Mah… - Transplant …, 2023 - frontierspartnerships.org
The organ donation and transplantation program in Spain has long been considered the
gold standard worldwide. An in-depth understanding of the Spanish program may promote …
gold standard worldwide. An in-depth understanding of the Spanish program may promote …
RICORS2040: the need for collaborative research in chronic kidney disease
A Ortiz - Clinical kidney journal, 2022 - academic.oup.com
Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of
CKD is relatively young and uptake by the public, physicians and health authorities is not …
CKD is relatively young and uptake by the public, physicians and health authorities is not …
Detección de factores de riesgo de enfermedad renal crónica en adultos
AM Iraizoz Barrios, G Brito Sosa… - Revista Cubana de …, 2022 - scielo.sld.cu
Introducción: La enfermedad renal crónica se considera una enfermedad con graves
repercusiones para la sociedad y las políticas de salud, con elevada incidencia y …
repercusiones para la sociedad y las políticas de salud, con elevada incidencia y …
The role of disturbed Mg homeostasis in chronic kidney disease comorbidities
C Rodelo-Haad, MV Pendón-Ruiz de Mier… - Frontiers in cell and …, 2020 - frontiersin.org
Some of the critical mechanisms that mediate chronic kidney disease (CKD) progression are
associated with vascular calcifications, disbalance of mineral metabolism, increased …
associated with vascular calcifications, disbalance of mineral metabolism, increased …
CKD: The burden of disease invisible to research funders
M Roger, A Osuna Ortega, MC De Gracia Guindo… - 2021 - digibug.ugr.es
The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians
and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or …
and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or …
[PDF][PDF] Prevalence, cardiometabolic comorbidities and reporting of chronic kidney disease; a Hungarian cohort analysis
A Zemplényi, E Sághy, A Kónyi, L Szabó… - … Journal of Public …, 2023 - ssph-journal.org
Objectives: Chronic kidney disease (CKD) implies increased comorbidity burden, disability,
and mortality, becoming a significant public health problem worldwide, however, prevalence …
and mortality, becoming a significant public health problem worldwide, however, prevalence …
[HTML][HTML] Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain
C Escobar, U Aranda, B Palacios, M Capel, A Sicras… - nefrologia, 2021 - Elsevier
Objectives To describe the epidemiology, clinical profile, treatments, and to determine
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic …
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic …
MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
S Fernández-Villabrille, B Martín-Carro… - Nephrology Dialysis …, 2023 - academic.oup.com
Introduction MicroRNAs (miRs) regulate vascular calcification (VC), and their quantification
may contribute to suspicion of the presence of VC. Methods The study was performed in four …
may contribute to suspicion of the presence of VC. Methods The study was performed in four …
Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population
C Santos-Araújo, L Mendonça… - Clinical Kidney …, 2023 - academic.oup.com
Chronic kidney disease (CKD) represents a global public health burden, but its true
prevalence is not fully characterized in the majority of countries. We studied the CKD …
prevalence is not fully characterized in the majority of countries. We studied the CKD …